Department of Health Policy and Administration, Pennsylvania State University, University Park.
Penn State Cancer Institute, Hershey, PA.
Med Care. 2019 Jul;57(7):494-497. doi: 10.1097/MLR.0000000000001107.
The main purpose of this study was to estimate the tax revenue lost by state and federal governments as a result of adverse labor market outcomes attributable to opioid misuse.
We pair existing, plausibly causal estimates of the effect of opioid misuse on the decline in the labor force from 2000 to 2016 with a variety of data sources to compute tax revenues lost by state and federal governments using the online TAXSIM calculator.
We find that between 2000 and 2016, opioid misuse cost state governments $11.8 billion, including $1.7 billion in lost sales tax revenue and $10.1 billion in lost income tax revenue. In addition, the federal government lost $26.0 billion in income tax revenue.
By omitting lost tax revenue due to labor force exits, prior studies have missed an important component of opioid-related costs borne by state and federal governments.
As more states and the federal government contemplate litigation for opioid-related damages, lost tax revenue represents an important cost that could be recouped and allocated to opioid prevention and treatment programs.
本研究的主要目的是估算由于阿片类药物滥用导致劳动力市场结果不利,州和联邦政府所损失的税收。
我们将阿片类药物滥用对 2000 年至 2016 年劳动力下降的影响的现有、合理的因果估计与各种数据源进行配对,使用在线 TAXSIM 计算器计算州和联邦政府损失的税收。
我们发现,2000 年至 2016 年间,阿片类药物滥用使州政府损失了 118 亿美元,其中包括 17 亿美元的销售税损失和 101 亿美元的所得税损失。此外,联邦政府损失了 260 亿美元的所得税收入。
由于劳动力流失导致的税收损失被先前的研究所忽略,因此忽略了州和联邦政府承担的与阿片类药物相关的成本的一个重要组成部分。
随着越来越多的州和联邦政府考虑对阿片类药物相关损害提起诉讼,失去的税收代表了一个可以收回并分配给阿片类药物预防和治疗计划的重要成本。